Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (6)

Company Market Cap Price
FMS Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care manufactures and provides Blood Purification Devices used in dialysis, including the 5008X CAREsystem.
$15.75B
$26.83
+0.56%
OM Outset Medical, Inc.
Tablo functions as a blood purification device used for dialysis; tag as Blood Purification Devices.
$232.52M
$13.13
+4.00%
SIGY Sigyn Therapeutics, Inc.
Sigyn Therapy is a broad-spectrum blood purification device designed to remove pathogens, toxins, and inflammatory mediators from blood.
$68.37M
$2.00
CTSO Cytosorbents Corporation
CytoSorbents' core offering is the CytoSorb blood purification device used in ICU and cardiac surgery to remove inflammatory mediators and toxins.
$49.78M
$0.80
+2.15%
ICU SeaStar Medical Holding Corporation
Core product is a blood purification device (SCD) used in critical care to modulate immune response and remove inflammatory mediators, fitting Blood Purification Devices.
$6.02M
$0.57
+2.85%
AEMD Aethlon Medical, Inc.
Hemopurifier is a blood purification device, the core product offering of Aethlon Medical.
$1.36M
$5.51
+1.47%

Loading company comparison...

Loading research report...

FMS Fresenius Medical Care AG & Co. KGaA

Joseph Turk Appointed New Management Board Member and CEO for Care Enablement Segment

Oct 01, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Increases Ownership in Interwell Health, Appoints New Value-Based Care CEO

Sep 18, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Initiates First Tranche of €1 Billion Share Buyback Program

Aug 11, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Delivers Strong Q2 2025 Organic Revenue and Double-Digit Operating Income Growth, Confirms Outlook and Share Buyback Initiation

Aug 05, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Frenova, Fresenius Medical Care's CRO, Collaborates with Azenta Life Sciences and Nephronomics for Genomics Research

Jul 31, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Partners with Mexico's CCINSHAE to Expand High-Volume Hemodiafiltration Access

Jul 03, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Unveils 'FME Reignite' Strategy, Targets Mid-Teens Operating Income Margins by 2030 and Announces €1 Billion Share Buyback

Jun 17, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem Following FDA Clearance

Jun 04, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Shareholders Approve Record Dividend at Annual General Meeting

May 22, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Starts 2025 with Strong Organic Revenue and Income Growth in Q1

May 06, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Publishes 2024 Annual Report, Highlighting Momentum and Strategic Progress

Mar 13, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Shares Fall Following Fresenius SE Stake Sale

Mar 04, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Delivers 18% Earnings Growth in 2024, Raises FME25 Savings Target, and Proposes 21% Dividend Increase

Feb 25, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Divests Select Laboratory Assets to Quest Diagnostics, Forms Strategic Partnership

Feb 24, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Recognized in Dow Jones Sustainability World and Europe Indices

Dec 23, 2024
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Returns to Prestigious DAX 40 Index

Dec 20, 2024
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc.

Nov 19, 2024
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Reports Strong Q3 2024 Operating Income Growth and Tightens Full-Year Outlook

Nov 05, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks